Investigator

Year(s) funded

Institution/Dept

Research Emphasis

Present Position

Jesus Gomez-Navarro, Ph.D.

1999-2000

UAB/Gene Therapy

Approaches to utilize mesenchymal progenitor cells as cellular vehicles

Associate Director of Clinical Oncology, Pfizer Pharmaceuticals

Ramon Alemany, Ph.D.

2000-2001

UAB/Gene Therapy

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus

Research Scientist Institut Catala d'Oncologia Barcelona , Spain

Selvarangan Ponnazhagan, Ph.D.

2000-2002

UAB/Pathology

Long-term anti-angiogenic gene therapy for ovarian cancer

Associate Professor Department of Pathology UAB

Tong Zhou, M.D.

2000-2004

UAB/Immunology, Rheumatology

DR-5 mediated apoptosis in ovarian cancer

Associate Professor Rheumatology/Immunology UAB

Alexander Pereboev, Ph.D.

2001-2002

UAB/Gene Therapy

Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells

Research Assistant Professor Human Gene Therapy UAB

Sharmila Makhija , MD

2001-2002

UAB/Ob-Gyn

Transcriptional targeted anti-angiogenesis gene therapy for ovarian cancer

Assistant Professor Department of Ob/Gyn UAB

Jerry Blackwell, Ph.D.

2002-2003

UAB/Gene Therapy

Cellular vehicles for ovarian cancer

Professor

Yerkes Nat'l Primate Res Ctr

Emory University , Atlanta , GA

Parameshwar Mahasreshti, D.V.M.

2002-2004

UAB/Ob-Gyn

Adenoviral-mediated mda-7 gene therapy for ovarian carcinoma

Research Assistant Professor Department of Ob/Gyn UAB

Helen Kim, Ph.D.

2002-2004

UAB/Pharmacology

Proteomic identification of protein markers of ovarian cancer

Research Associate Professor Department of Pharmacology & Toxicology, UAB

Susan Murphy, Ph.D.

2003-2004

Duke/Ob-Gyn

Ovarian cancer and Yin-Yang 1: expression and survival

Research Assistant Professor Department of Ob/Gyn Duke